Dr. Douglas Dieterich: “Cheap Allergy Drug May Be Effective For Hepatitis C”
Preliminary lab research suggests a hay fever drug that costs about 50 cents a pill has the potential to treat hepatitis C, a stubborn disease that has spawned drugs that sell for $1,000 a dose. Hepatitis C often leads to serious liver complications such as cirrhosis. Some expensive new medications are "astonishingly effective" with cure rates of more than 90 percent, said Douglas Dieterich, MD, a professor of liver diseases at Icahn School of Medicine at Mount Sinai in New York City. It's too early to know if the antihistamine chlorcyclizine HCI will work in people as a treatment for hepatitis C. Still, the new research suggests that the drug blocks the virus getting into cells and is different from the current hepatitis C drugs, which block viral replication. Learn more
Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Aug 04, 2022 View All Press Releases
Mount Sinai Researcher Receives Prestigious International Award
Jul 06, 2022 View All Press Releases
